A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders

A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders

Conditions: Multiple Myeloma
Interventions: Other: Lecture on the role of cellular therapies in relapse/refractory multiple myeloma/RRMM; Behavioral: Hospital Anxiety and Depression Scale; Behavioral: Duke-UNC Functional Social Support Questionnaire; Behavioral: Distress Thermometer; Behavioral: FACT-BMT; Behavioral: Psychosocial Assessments of Candidates for Transplantation
Sponsors: Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 16, 2023Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments